This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring

€500 savings end in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
THE SPRINGTIME PARTNERING EVENT
March 18–20, 2024 | Barcelona, SpainMarch 26–27, 2024 | Digital Partnering

Inhibitec Anticuerpos SL

Profile

Inhibitec is a biotech company with the mission to develop a novel therapeutic approach for the treatment of inflammatory chronic and autoimmune diseases. Inhibitec is a startup company with its foundation on the Spanish National Research Council (CSIC) and the University of Cantabria (UC). Our main goal is to position B101.37, a specific monoclonal antibody targeting BAMBI (BMP and Activin Membrane-Bound Inhibitor), as a new standard in the treatment of psoriasis and psoriatic arthritis (PsA).